Overview
Congenital lobar emphysema (CLE), also known as congenital lobar overinflation or infantile lobar emphysema, is a rare developmental anomaly of the lung characterized by hyperinflation of one or more pulmonary lobes. The condition results from overdistension of the alveoli within the affected lobe, leading to air trapping and progressive expansion of lung tissue. This hyperinflated lobe can compress adjacent normal lung tissue and may cause mediastinal shift, compromising respiratory and cardiovascular function. The left upper lobe is most commonly affected, followed by the right middle lobe and right upper lobe. Lower lobes are rarely involved. CLE primarily affects the respiratory system and typically presents in the neonatal period or early infancy with progressive respiratory distress, tachypnea, wheezing, cyanosis, and difficulty feeding. In some cases, the condition may be detected prenatally on ultrasound or may remain asymptomatic and be discovered incidentally on chest imaging. The underlying cause is often idiopathic, though in some cases it may be associated with deficiency or dysplasia of bronchial cartilage, external bronchial compression by aberrant vessels, or endobronchial obstruction such as mucus plugging or mucosal folds. CLE can occasionally occur in association with congenital heart defects or other congenital anomalies. Management depends on the severity of symptoms. Severely symptomatic neonates and infants typically require surgical intervention, with lobectomy (surgical removal of the affected lobe) being the definitive treatment and generally yielding excellent outcomes. Mildly symptomatic or asymptomatic patients may be managed conservatively with close monitoring, as some cases may stabilize or improve over time. Prognosis after surgical treatment is generally very good, with most children achieving normal lung function and growth. Early diagnosis and appropriate management are essential to prevent life-threatening respiratory compromise.
Clinical phenotype terms— hover any for plain English:
Sporadic
Usually appears on its own, not inherited from a parent
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Congenital lobar emphysema.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Congenital lobar emphysema at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Congenital lobar emphysema.
Community
No community posts yet. Be the first to share your experience with Congenital lobar emphysema.
Start the conversation →Latest news about Congenital lobar emphysema
No recent news articles for Congenital lobar emphysema.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Congenital lobar emphysema
What is Congenital lobar emphysema?
Congenital lobar emphysema (CLE), also known as congenital lobar overinflation or infantile lobar emphysema, is a rare developmental anomaly of the lung characterized by hyperinflation of one or more pulmonary lobes. The condition results from overdistension of the alveoli within the affected lobe, leading to air trapping and progressive expansion of lung tissue. This hyperinflated lobe can compress adjacent normal lung tissue and may cause mediastinal shift, compromising respiratory and cardiovascular function. The left upper lobe is most commonly affected, followed by the right middle lobe a
How is Congenital lobar emphysema inherited?
Congenital lobar emphysema follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Congenital lobar emphysema typically begin?
Typical onset of Congenital lobar emphysema is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Congenital lobar emphysema?
1 specialists and care centers treating Congenital lobar emphysema are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.